Heterozygous Familial Hypercholesterolemia - Onorato, A.; Sturm, A. C. (Circulation, 2016)

Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia - Hopkins, P. N.; Toth, P. P.; Ballantyne, C. M.; Rader, D. J. (J Clin Lipidol, 2011)

A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia - Marks, D.; Thorogood, M.; Neil, H. A.; Humphries, S. E. (Atherosclerosis, 2003)

Elevated PCSK9 levels in untreated patients with heterozygous or homozygous familial hypercholesterolemia and the response to high-dose statin therapy - Raal, F.; Panz, V.; Immelman, A.; Pilcher, G. (J Am Heart Assoc, 2013)

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur - Nordestgaard, B. G. (Heart J, 2013)

Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication - Benn, M.; Watts, G. F.; Tybjaerg-Hansen, A.; Nordestgaard, B. G. (J Clin Endocrinol Metab, 2012)

Familial hypercholesterolemia among unselected contemporary patients presenting with first myocardial infarction: Prevalence, risk factor burden, and impact on age at presentation - Mortensen, M. B.; Kulenovic, I.; Klausen, I. C.; Falk, E. (J Clin Lipidol, 2016)

Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction - Grundy, S. M. (American Heart Association. Circulation, 1998)

Should we be measuring blood cholesterol levels in young adults? - Hulley, S. B. (Jama, 1993)

A common mutation in the lipoprotein lipase gene (N291S) alters the lipoprotein phenotype and risk for cardiovascular disease in patients with familial hypercholesterolemia - Wittekoek, M. E. (Circulation, 1998)

Identification of familial hypercholesterolemia in patients with myocardial infarction: A Chinese cohort study - Li, S. (J Clin Lipidol, 2016)

Mild hypercholesterolemia and premature heart disease: do the national criteria underestimate disease risk? - Akosah, K. O.; Gower, E.; Groon, L.; Rooney, B. L.; Schaper, A. (J Am Coll Cardiol, 2000)

Myocardial infarction in young adults with low-density lipoprotein cholesterol levels or = 100 mg/dL: clinical profile and 1-year outcomes - Akosah, K. O.; Cerniglia, R. M.; Havlik, P.; Schaper, A. (Chest, 2001)

The severe hypercholesterolemia phenotype: clinical diagnosis, management, and emerging therapies - Sniderman, A. D.; Tsimikas, S.; Fazio, S. (J Am Coll Cardiol, 2014)

Polygenic familial hypercholesterolaemia: does it matter? - Stein, E. A.; Raal, F. J. (Lancet, 2013)

The prevalence and prognostic importance of possible familial hypercholesterolemia in patients with myocardial infarction - Rerup, S. A. (Am Heart J, 2016)

Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales - Haralambos, K. (Atherosclerosis, 2015)

The very high cardiovascular risk in heterozygous familial hypercholesterolemia: Analysis of 734 French patients - Beliard, S. (J Clin Lipidol, 2016)

[Diagnostic and treatment of familial hypercholesterolemia (FH) in adult: guidelines from the New French Society of Atherosclerosis (NSFA)] - Farnier, M.; Bruckert, E.; Boileau, C.; Krempf, M. (Presse Med, 2013)

Treatment of adults with familial hypercholesterolemia and evidence for treatment: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia - Robinson, J. G.; Goldberg, A. C. (J Clin Lipidol, 2011)

Angiographic score assessment improves cardiovascular risk prediction: the clinical value of SYNTAX and Gensini application - Sinning, C. (Clin Res Cardiol, 2013)

A more meaningful scoring system for determining the severity of coronary heart disease - Gensini, G. G. (Am J Cardiol, 1983)

Proprotein Convertase Subtilisin/Kexin type 9, C-Reactive Protein, Coronary Severity, and Outcomes in Patients With Stable Coronary Artery Disease: A Prospective Observational Cohort Study - Li, J. J. (Medicine (Baltimore), 2015)

Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation - Alonso, R. (J Am Coll Cardiol, 2014)

Lipoprotein(a) and cardiovascular disease in heterozygous familial hypercholesterolemia: should we also blame the LDL receptor? - Santos, R. D. (J Am Coll Cardiol, 2014)

Serum lipids and lipoproteins in Chinese men and women - Yang, W. (Circulation, 2012)

APACHE-II score and Killip class for patients with acute myocardial infarction - Mercado-Martinez, J. (Intensive Care Med, 2010)

Prevalence of heterozygous familial hypercholesterolaemia and its impact on long-term prognosis in patients with very early ST-segment elevation myocardial infarction in the era of statins - Rallidis, L. S. (Atherosclerosis, 2016)

Familial hypercholesterolemia in Chinese patients with premature ST-segment-elevation myocardial infarction: Prevalence, lipid management and 1-year follow-up - Auckle, R. (PLoS One, 2017)

Prevalence and management of familial hypercholesterolaemia in coronary patients: An analysis of EUROASPIRE IV, a study of the European Society of Cardiology - Backer, G. (Atherosclerosis, 2015)

Phenotypic variation in heterozygous familial hypercholesterolemia: a comparison of Chinese patients with the same or similar mutations in the LDL receptor gene in China or Canada - Pimstone, S. N. (Arterioscler Thromb Vasc Biol, 1998)

Cannon, C. P. et al. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. New England Journal of Medicine372(25), 2387–2397 (2015).

Besseling, J., Hovingh, G. K., Huijgen, R., Kastelein, J. J. & Hutten, B. A. Statins in Familial Hypercholesterolemia: Consequences for Coronary Artery Disease and All-Cause Mortality. J Am Coll Cardiol68, 252–260, https://doi.org/10.1016/j.jacc.2016.04.054 (2016).

Perez de Isla, L. et al. Attainment of LDL-Cholesterol TreatmentÂ Goals in Patients With FamilialÂ Hypercholesterolemia. Journal of the American College of Cardiology67(11), 1278–1285 (2016).